202 related articles for article (PubMed ID: 11767127)
1. Serological tumor markers for monitoring breast cancer.
Sölétormos G
Dan Med Bull; 2001 Nov; 48(4):229-55. PubMed ID: 11767127
[No Abstract] [Full Text] [Related]
2. Comparison of CEA, MCA, CA 15-3 and CA 27-29 in follow-up and monitoring therapeutic response in breast cancer patients.
Lauro S; Trasatti L; Bordin F; Lanzetta G; Bria E; Gelibter A; Reale MG; Vecchione A
Anticancer Res; 1999; 19(4C):3511-5. PubMed ID: 10629644
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of four serological tumor markers for the detection of breast cancer.
Clinton SR; Beason KL; Bryant S; Johnson JT; Jackson M; Wilson C; Holifield K; Vincent C; Hall M
Biomed Sci Instrum; 2003; 39():408-14. PubMed ID: 12724928
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of CA 549, a circulating marker of breast cancer using a procedure for comparison with CA 15.3.
Cazin JL; Gosselin P; Boniface B; Demaille MC; Demaille A
Anticancer Res; 1992; 12(3):719-24. PubMed ID: 1622129
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the BT-1 serum assay for breast cancer.
Whitehurst MM; Aldenderfer PH; Sooy MM; Strelkauskas AJ
Hum Antibodies; 1999; 9(3):155-60. PubMed ID: 10690628
[TBL] [Abstract][Full Text] [Related]
6. [Tumor markers in breast cancer].
Kurebayashi J
Gan To Kagaku Ryoho; 2004 Nov; 31(12):2077-81. PubMed ID: 15570944
[TBL] [Abstract][Full Text] [Related]
7. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
Kurebayashi J; Nomura T; Hirono M; Okubo S; Udagawa K; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Sonoo H
Jpn J Clin Oncol; 2006 Mar; 36(3):150-3. PubMed ID: 16520359
[TBL] [Abstract][Full Text] [Related]
8. Serum tumor markers in patients with breast cancer.
Lumachi F; Basso SM
Expert Rev Anticancer Ther; 2004 Oct; 4(5):921-31. PubMed ID: 15485325
[TBL] [Abstract][Full Text] [Related]
9. [Tumor markers in metastatic breast carcinoma: correlations with clinical response].
Winer Y; Martini MC; Pastorino G; Moraglio L; Vallauri M; Brondi P; Brema F
J Nucl Med Allied Sci; 1990; 34(4 Suppl):127-30. PubMed ID: 2092107
[No Abstract] [Full Text] [Related]
10. The early detection of disseminated (metastasized) breast cancer by serial tumour marker measurements.
Jäger W
Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():133-9. PubMed ID: 8298443
[No Abstract] [Full Text] [Related]
11. First experiences with the use of CASA in mammary carcinoma.
Weise J; Meisel M; Straube W
Anticancer Res; 1997; 17(4B):3039-40. PubMed ID: 9329596
[TBL] [Abstract][Full Text] [Related]
12. [BCA225].
Kumamoto K; Kannagi R
Nihon Rinsho; 2005 Aug; 63 Suppl 8():669-71. PubMed ID: 16149607
[No Abstract] [Full Text] [Related]
13. Serum CYFRA 21-1 is one of the most reliable tumor markers for breast carcinoma.
Rodríguez CA; Cruz JJ; Martín T; Gómez A; Olaverri A; Hernández M
Cancer; 2002 Aug; 95(3):670-1; author reply 671. PubMed ID: 12209762
[No Abstract] [Full Text] [Related]
14. Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients.
Alix-Panabières C; Brouillet JP; Fabbro M; Yssel H; Rousset T; Maudelonde T; Choquet-Kastylevsky G; Vendrell JP
J Immunol Methods; 2005 Apr; 299(1-2):177-88. PubMed ID: 15914200
[TBL] [Abstract][Full Text] [Related]
15. Tumor associated glycoprotein (TAG) 12: a new tumor marker in breast cancer.
Heinze T; Lichtenegger W
Anticancer Res; 2000; 20(6D):5049-52. PubMed ID: 11326666
[TBL] [Abstract][Full Text] [Related]
16. [Pre- and post-therapeutic serum concentrations of mucin-like carcinoma-associated antigen in patients with breast cancer].
Fuith LC; Artner-Dworzak E; Schröcksnadel H; Müller-Holzner E; Daxenbichler G; Heim K
Gynakol Rundsch; 1989; 29 Suppl 2():397-9. PubMed ID: 2613061
[No Abstract] [Full Text] [Related]
17. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
Ławicki S; Szmitkowski M; Wojtukiewicz M
Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
[TBL] [Abstract][Full Text] [Related]
18. [Serum markers in breast cancer and colorectal cancer (1997)].
Bellet D; Mlika-Cabanne N; Bedenne L; Brun B; Demeaux JL; Legrand JL; Lorimier G; Mignotte H; Ollivier JM; Piperno-Neumann S; Rinaldi Y; Rousset H; Rymer JC; Laversin S
Gynecol Obstet Fertil; 2001 Jan; 29(1):62-3. PubMed ID: 11217195
[No Abstract] [Full Text] [Related]
19. [Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].
Zheng H; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1293-4, 1298. PubMed ID: 16234113
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer markers during normal pregnancy.
Botsis D; Sarandakou A; Kassanos D; Kontoravdis A; Rizos D; Protonotariou E; Phocas I; Creatsas G
Anticancer Res; 1999; 19(4C):3539-41. PubMed ID: 10629649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]